RxDoctor Payments Data

Kevin Parks, MD

Allergy · Medford, ORNPI 1467499475

Payments from drug & device makers

$242,913in general payments, 2019–2025

Across 67 payments — averaging $3625.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$71K
  • Sanofi Pasteur Inc.$58K
  • Incyte Corporation$28K
  • Hikma Pharmaceuticals USA$28K
  • AstraZeneca$21K
  • GSK$12K
  • plus $25K from 5 others

What the payments were for

  • Food & beverage$37100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few allergy providers in Oregonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$131,762
Medicare patients
507
Services billed
8,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HaegardaC1 Esterase Inhibitor11$463,825
Dupixent PenDupilumab43$175,420
Gamunex-CImmune Globul G/Gly/Iga Avg 4613$67,787
Dupixent SyringeDupilumab12$43,767
XolairOmalizumab12$31,192
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$27,405
Fluticasone-SalmeterolFluticasone Propion/Salmeterol76$17,014
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate47$15,923
Breo ElliptaFluticasone/Vilanterol14$12,308
Advair HfaFluticasone Propion/Salmeterol23$11,893
Albuterol Sulfate HfaAlbuterol Sulfate158$9,537
Arnuity ElliptaFluticasone Furoate16$8,882
SymbicortBudesonide/Formoterol Fumarate12$7,129
BreynaBudesonide/Formoterol Fumarate14$6,638
Epinephrine21$5,121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$11,500$48,59661 claims
AstraZenecaSymbicort$21,259$7,12912 claims
Hikma Pharmaceuticals USAEpinephrine$27,835$5,12121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Oregonon file to place this against a meaningful peer group, so we don't.

Other allergy in Medford

Where these figures come from

Is this you, or does something look wrong? →